55
Claris Biotherapeutics, Inc. raises $55.7M under Reg D
Company raise · Raising · Offering $121.5M · Sold $55.7M · HALF MOON BAY, CA · filed 2026-08-07
35
Claris Biotherapeutics, Inc. files Form D
Company raise update · Raising · HALF MOON BAY, CA · Form D/A filed 2026-08-12
$50M+ raise
Why now — by persona
Relevant to: B2B software & services sales. Lead card pending.
People on the filing
| Brian Baum | Executive Officer |
| Meredith Fisher | Director |
| Reza Dana | Director |
| Stephen Brady | Executive Officer, Director |
| Henry Rath | Executive Officer |
| Kenneth Harrison | Director |
| Matt Hobson | Director |
| Michael Dybbs | Director |
| Maha Radhakrishnan | Director |
| Susan Orr | Executive Officer |
| Clarke Atwell | Executive Officer |
| Marc de Garidel | Director |
Signed by Henry Rath, Chief Business Officer.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.
Other filings by this issuer
40
Claris Biotherapeutics, Inc. raises $2.3M under Reg D
Company raise · Closed · Offering $2.3M · Sold $2.3M · JERSEY CITY, NJ · filed 2025-09-22
45
Claris Biotherapeutics, Inc. raises $3.3M under Reg D
Company raise · Raising · Offering $3.3M · Sold $3.3M · JERSEY CITY, NJ · filed 2025-03-07